Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Practice Guidelines for Bladder Cancer 2019 edition by the Japanese Urological Association: Revision working position paper.
Matsumoto H, Shiraishi K, Azuma H, Inoue K, Uemura H, Eto M, Ohyama C, Ogawa O, Kikuchi E, Kitamura H, Shinohara N, Takahashi S, Tsuzuki T, Nakagawa M, Narumi Y, Nishiyama H, Habuchi T, Hinotsu S, Fujii Y, Fujimoto K, Fujimoto H, Mizowaki T, Matsuyama H. Matsumoto H, et al. Among authors: hinotsu s. Int J Urol. 2020 May;27(5):362-368. doi: 10.1111/iju.14210. Epub 2020 Mar 14. Int J Urol. 2020. PMID: 32172529
Treated natural history of superficial bladder cancer.
Ozono S, Hinotsu S, Tabata S, Takashima K, Fujimoto K, Okajima E, Hirao Y, Ohashi Y, Akaza H, Fukushima S; Nara Uro-Oncology Research Group. Ozono S, et al. Among authors: hinotsu s. Jpn J Clin Oncol. 2001 Nov;31(11):536-40. doi: 10.1093/jjco/hye114. Jpn J Clin Oncol. 2001. PMID: 11773261
[Intravesical instillation of doxorubicin or epirubicin for chemoprophylaxis of superficial bladder cancer--the fifth study of the Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin].
Hinotsu S, Akaza H, Isaka S, Kagawa S, Koiso K, Kotake T, Machida T, Matsumura Y, Niijima T, Obata K, Ohashi Y, Ohe H, Shimazaki J, Tashiro K; Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin. Hinotsu S, et al. Gan To Kagaku Ryoho. 2002 Jan;29(1):73-80. Gan To Kagaku Ryoho. 2002. PMID: 11816482 Clinical Trial. Japanese.
The 2nd conference on Asian trends in prostate cancer hormone therapy.
Akaza H, Chang SJ, Chen KK, Esuvaranathan K, Fujioka T, Hirao Y, Hong SJ, Hinotsu S, Kim WJ, Lau W, Lee SE, Murai M, Naito S, Ogawa O, Rim JS, Soebadi DM, Song JM, Tsukamoto T, Umbas R, Usami M, Yang CR, Yoon JH, Zhou L. Akaza H, et al. Among authors: hinotsu s. Gan To Kagaku Ryoho. 2003 Oct;30(10):1533-42. Gan To Kagaku Ryoho. 2003. PMID: 14584292
Effect of prophylactic treatment with intravesical epirubicin on recurrence of superficial bladder cancer--The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG): a randomized trial of intravesical epirubicin at dose of 20mg/40ml, 30mg/40ml, 40mg/40ml.
Kuroda M, Niijima T, Kotake T, Akaza H, Hinotsu S; 6th Trial of the Japanese Urological Cancer Research Group. Kuroda M, et al. Among authors: hinotsu s. Eur Urol. 2004 May;45(5):600-5. doi: 10.1016/j.eururo.2003.12.010. Eur Urol. 2004. PMID: 15082202 Clinical Trial.
217 results